Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 645

1.

Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: A Systematic Review and Meta-Analysis.

Elsebaie MA, van Es N, Langston A, Büller HR, Gaddh M.

J Thromb Haemost. 2019 Jan 28. doi: 10.1111/jth.14398. [Epub ahead of print]

PMID:
30690830
2.

Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.

Cohen AT, Agnelli G, Buller HR, Gallus A, Raskob GE, Sanders P, Thompson J, Weitz JI.

Thromb Haemost. 2019 Jan 16. doi: 10.1055/s-0038-1676983. [Epub ahead of print]

PMID:
30650446
3.

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.

Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N, Smit K, Büller HR, van Es N; CAT prediction collaborators; CAT-prediction collaborators.

Haematologica. 2019 Jan 3. pii: haematol.2018.209114. doi: 10.3324/haematol.2018.209114. [Epub ahead of print]

4.

Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.

Wang KL, Lopes RD, Patel MR, Büller HR, Tan DS, Chiang CE, Giugliano RP.

Eur Heart J. 2018 Dec 22. doi: 10.1093/eurheartj/ehy802. [Epub ahead of print]

PMID:
30590440
5.

Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

van Mens TE, Büller HR, Nieuwdorp M.

J Thromb Haemost. 2019 Jan;17(1):3-5. doi: 10.1111/jth.14331. Epub 2018 Dec 10. No abstract available.

PMID:
30548165
6.

Extended treatment of venous thromboembolism: a systematic review and network meta-analysis.

Wang KL, van Es N, Cameron C, Castellucci LA, Büller HR, Carrier M.

Heart. 2018 Oct 16. pii: heartjnl-2018-313617. doi: 10.1136/heartjnl-2018-313617. [Epub ahead of print]

PMID:
30327391
7.

Direct oral anticoagulants in patients with liver cirrhosis: A systematic review.

Hoolwerf EW, Kraaijpoel N, Büller HR, van Es N.

Thromb Res. 2018 Oct;170:102-108. doi: 10.1016/j.thromres.2018.08.011. Epub 2018 Aug 17. Review.

PMID:
30153564
8.

Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.

Bleker SM, Brekelmans MPA, Eerenberg ES, Cohen AT, Middeldorp S, Raskob G, Büller HR.

Thromb Haemost. 2017 Oct;117(10):1944-1951. doi: 10.1160/TH16-12-0946. Epub 2017 Nov 28.

PMID:
30151820
9.

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.

Kraaijpoel N, Di Nisio M, Mulder FI, van Es N, Beyer-Westendorf J, Carrier M, Garcia D, Grosso M, Kakkar AK, Mercuri MF, Middeldorp S, Hernandez CR, Santamaria A, Schwocho L, Segers A, Verhamme P, Wang TF, Weitz JI, Zhang G, Zwicker JI, Büller HR, Raskob GE.

Thromb Haemost. 2018 Aug;118(8):1439-1449. doi: 10.1055/s-0038-1667001. Epub 2018 Jul 30.

PMID:
30060256
10.

Edoxaban for Cancer-Associated Venous Thromboembolism.

Raskob GE, Büller HR, Segers A.

N Engl J Med. 2018 Jul 5;379(1):95-96. doi: 10.1056/NEJMc1806646. No abstract available.

PMID:
29972743
11.

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.

Scheres L, Brekelmans M, Ageno W, Ay C, Büller HR, Eichinger S, Hutten BA, Klok FA, Middeldorp S, Schreiber K, Stach K, Blondon M, Delluc A.

BJOG. 2018 Nov;125(12):1581-1589. doi: 10.1111/1471-0528.15388. Epub 2018 Jul 20.

12.

A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.

Pabinger I, van Es N, Heinze G, Posch F, Riedl J, Reitter EM, Di Nisio M, Cesarman-Maus G, Kraaijpoel N, Zielinski CC, Büller HR, Ay C.

Lancet Haematol. 2018 Jul;5(7):e289-e298. doi: 10.1016/S2352-3026(18)30063-2. Epub 2018 Jun 7. Erratum in: Lancet Haematol. 2018 Jun 15;:.

13.

Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.

Kraaijpoel N, van Es N, Raskob GE, Büller HR, Carrier M, Zhang G, Lin M, Grosso MA, Di Nisio M.

Thromb Haemost. 2018 Jul;118(7):1270-1278. doi: 10.1055/s-0038-1649523. Epub 2018 Jun 4.

PMID:
29864787
14.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: comment.

Kraaijpoel N, Toorop MMA, Bossuyt PM, Klok FA, Büller HR, van Es N.

J Thromb Haemost. 2018 Jul;16(7):1445-1448. doi: 10.1111/jth.14133. Epub 2018 Jun 12. No abstract available.

PMID:
29733495
15.

NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands.

van den Heuvel JM, Hövels AM, Büller HR, Mantel-Teeuwisse AK, de Boer A, Maitland-van der Zee AH.

Thromb J. 2018 Apr 18;16:7. doi: 10.1186/s12959-017-0156-y. eCollection 2018.

16.

Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.

van Es N, Hisada Y, Di Nisio M, Cesarman G, Kleinjan A, Mahé I, Otten HM, Kamphuisen PW, Berckmans RJ, Büller HR, Mackman N, Nieuwland R.

Thromb Res. 2018 Jun;166:54-59. doi: 10.1016/j.thromres.2018.04.009. Epub 2018 Apr 10.

PMID:
29656167
17.

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.

Spronk HMH, Padro T, Siland JE, Prochaska JH, Winters J, van der Wal AC, Posthuma JJ, Lowe G, d'Alessandro E, Wenzel P, Coenen DM, Reitsma PH, Ruf W, van Gorp RH, Koenen RR, Vajen T, Alshaikh NA, Wolberg AS, Macrae FL, Asquith N, Heemskerk J, Heinzmann A, Moorlag M, Mackman N, van der Meijden P, Meijers JCM, Heestermans M, Renné T, Dólleman S, Chayouâ W, Ariëns RAS, Baaten CC, Nagy M, Kuliopulos A, Posma JJ, Harrison P, Vries MJ, Crijns HJGM, Dudink EAMP, Buller HR, Henskens YMC, Själander A, Zwaveling S, Erküner O, Eikelboom JW, Gulpen A, Peeters FECM, Douxfils J, Olie RH, Baglin T, Leader A, Schotten U, Scaf B, van Beusekom HMM, Mosnier LO, van der Vorm L, Declerck P, Visser M, Dippel DWJ, Strijbis VJ, Pertiwi K, Ten Cate-Hoek AJ, Ten Cate H.

Thromb Haemost. 2018 Feb;118(2):229-250. doi: 10.1160/TH17-07-0492. Epub 2018 Jan 29.

18.

Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.

Kraaijpoel N, van Es N, Bleker SM, Brekelmans MPA, Eerenberg ES, Middeldorp S, Cohen AT, Raskob GE, Büller HR.

Thromb Haemost. 2018 Jan;118(1):174-181. doi: 10.1160/TH17-04-0274. Epub 2018 Jan 5.

PMID:
29304537
19.

Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.

Vanassche T, Verhamme P, Wells PS, Segers A, Ageno W, Brekelmans MPA, Chen CZ, Cohen AT, Grosso MA, Medina AP, Mercuri MF, Winters SM, Zhang G, Weitz JI, Raskob GE, Büller HR.

Thromb Res. 2018 Feb;162:7-14. doi: 10.1016/j.thromres.2017.12.005. Epub 2017 Dec 13.

PMID:
29248859
20.

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.

Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators.

N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12.

21.

Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.

Medina A, Raskob G, Ageno W, Cohen AT, Brekelmans MPA, Chen CZ, Grosso MA, Mercuri MF, Segers A, Verhamme P, Vanassche T, Wells PS, Lin M, Winters SM, Weitz JI, Büller HR.

Thromb Haemost. 2017 Dec;117(12):2406-2414. doi: 10.1160/TH17-05-0523. Epub 2017 Dec 6.

22.

Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials.

Di Minno MND, Ageno W, Lupoli R, Conte G, van Es N, Buller HR, Dentali F.

Eur Respir J. 2017 Sep 27;50(3). pii: 1701097. doi: 10.1183/13993003.01097-2017. Print 2017 Sep. No abstract available.

PMID:
28954772
23.

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.

Khan F, Rahman A, Carrier M, Kearon C, Schulman S, Couturaud F, Prandoni P, Eichinger S, Becattini C, Agnelli G, Büller HR, Brighton TA, Palareti G, Pinede L, Sabri E, Hutton B, Wells GA, Rodger MA; MARVELOUS Collaborators.

BMJ Open. 2017 Sep 21;7(9):16950. doi: 10.1136/bmjopen-2017-016950.

24.

Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient Data.

van Es N, Le Gal G, Otten HM, Robin P, Piccioli A, Lecumberri R, Jara-Palomares L, Religa P, Rieu V, Rondina M, Beckers MM, Prandoni P, Salaun PY, Di Nisio M, Bossuyt PM, Büller HR, Carrier M.

Ann Intern Med. 2017 Sep 19;167(6):410-417. doi: 10.7326/M17-0868. Epub 2017 Aug 22. Review.

PMID:
28828492
25.

Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.

Bleker SM, Brekelmans MPA, Eerenberg ES, Cohen AT, Middeldorp S, Raskob G, Büller HR.

Thromb Haemost. 2017 Oct 5;117(10):1944-1951. doi: 10.1160/TH16-12-0946. Epub 2017 Aug 17.

PMID:
28816341
26.

Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score.

Robert-Ebadi H, Mostaguir K, Hovens MM, Kare M, Verschuren F, Girard P, Huisman MV, Moustafa F, Kamphuisen PW, Buller HR, Righini M, Le Gal G.

J Thromb Haemost. 2017 Sep;15(9):1764-1769. doi: 10.1111/jth.13770. Epub 2017 Aug 17.

PMID:
28688113
27.

Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis.

van Es N, Le Gal G, Otten HM, Robin P, Piccioli A, Lécumberri R, Jara-Palomares L, Religa P, Rieu V, Rondina MT, Beckers MM, Prandoni P, Salaun PY, Nisio MD, Bossuyt PM, Büller HR, Carrier M.

BMJ Open. 2017 Jun 10;7(6):e015562. doi: 10.1136/bmjopen-2016-015562. Erratum in: BMJ Open. 2017 Aug 11;7(8):e015562corr1.

28.

The diagnostic management of upper extremity deep vein thrombosis: A review of the literature.

Kraaijpoel N, van Es N, Porreca E, Büller HR, Di Nisio M.

Thromb Res. 2017 Aug;156:54-59. doi: 10.1016/j.thromres.2017.05.035. Epub 2017 Jun 1. Review.

PMID:
28586697
29.

Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis.

van der Hulle T, van Es N, den Exter PL, van Es J, Mos ICM, Douma RA, Kruip MJHA, Hovens MMC, Ten Wolde M, Nijkeuter M, Ten Cate H, Kamphuisen PW, Büller HR, Huisman MV, Klok FA.

Thromb Haemost. 2017 Jul 26;117(8):1622-1629. doi: 10.1160/TH17-02-0076. Epub 2017 Jun 1.

PMID:
28569924
30.

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study.

van Es N, Di Nisio M, Cesarman G, Kleinjan A, Otten HM, Mahé I, Wilts IT, Twint DC, Porreca E, Arrieta O, Stépanian A, Smit K, De Tursi M, Bleker SM, Bossuyt PM, Nieuwland R, Kamphuisen PW, Büller HR.

Haematologica. 2017 Sep;102(9):1494-1501. doi: 10.3324/haematol.2017.169060. Epub 2017 May 26.

31.

Sex-specific differences in the presenting location of a first venous thromboembolism.

Scheres LJJ, Brekelmans MPA, Beenen LFM, Büller HR, Cannegieter SC, Middeldorp S.

J Thromb Haemost. 2017 Jul;15(7):1344-1350. doi: 10.1111/jth.13712. Epub 2017 May 28.

PMID:
28440013
32.

Association between protein C levels and mortality in patients with advanced prostate, lung and pancreatic cancer.

Wilts IT, Hutten BA, Meijers JCM, Spek CA, Büller HR, Kamphuisen PW.

Thromb Res. 2017 Jun;154:1-6. doi: 10.1016/j.thromres.2017.03.001. Epub 2017 Mar 7.

PMID:
28376316
33.

Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function.

Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, Brekelmans MPA, Büller HR, Elias A, Farge D, Konstantinides S, Palareti G, Prandoni P, Righini M, Torbicki A, Vlachopoulos C, Brodmann M.

Eur Heart J. 2018 Dec 14;39(47):4208-4218. doi: 10.1093/eurheartj/ehx003. No abstract available.

PMID:
28329262
34.

Preference for direct oral anticoagulants in patients treated with vitamin K antagonists for venous thromboembolism.

Brekelmans MP, Kappelhof M, Nieuwkerk PT, Nierman M, Buller HR, Coppens M.

Neth J Med. 2017 Mar;75(2):50-55.

35.

Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism.

Wilts IT, Le Gal G, Den Exter PL, Van Es J, Carrier M, Planquette B, Büller HR, Righini M, Huisman MV, Kamphuisen PW.

Thromb Res. 2017 Apr;152:49-51. doi: 10.1016/j.thromres.2017.02.007. Epub 2017 Feb 13.

PMID:
28226257
36.

Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin.

Brekelmans MP, Scheres LJ, Bleker SM, Hutten BA, Timmermans A, Büller HR, Middeldorp S.

Thromb Haemost. 2017 Apr 3;117(4):809-815. doi: 10.1160/TH16-11-0874. Epub 2017 Feb 9.

PMID:
28180233
37.

Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.

Di Nisio M, Raskob G, Büller HR, Grosso MA, Zhang G, Winters SM, Cohen A.

Thromb Haemost. 2017 Apr 3;117(4):784-793. doi: 10.1160/TH16-11-0830. Epub 2017 Feb 2.

PMID:
28151543
38.

The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis.

van Es N, Kraaijpoel N, Klok FA, Huisman MV, Den Exter PL, Mos IC, Galipienzo J, Büller HR, Bossuyt PM.

J Thromb Haemost. 2017 Apr;15(4):678-684. doi: 10.1111/jth.13630. Epub 2017 Feb 16.

PMID:
28106338
39.

Extracranial arterial and venous thromboembolism in patients with atrial fibrillation: A meta-analysis of randomized controlled trials.

Wang KL, Büller HR, Goto S, Lin CY, Lai EY, Chiu CC, Chiang CE, Giugliano RP.

Heart Rhythm. 2017 Apr;14(4):599-605. doi: 10.1016/j.hrthm.2016.12.038. Epub 2017 Jan 4.

PMID:
28062249
40.

The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.

van Es N, Franke VF, Middeldorp S, Wilmink JW, Büller HR.

Thromb Res. 2017 Feb;150:30-32. doi: 10.1016/j.thromres.2016.12.013. Epub 2016 Dec 16.

PMID:
28002757
41.

Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism?

van Es N, van der Hulle T, Büller HR, Klok FA, Huisman MV, Galipienzo J, Di Nisio M.

J Thromb Haemost. 2017 Feb;15(2):323-328. doi: 10.1111/jth.13574. Epub 2016 Dec 24.

42.

A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients.

van Es N, Bleker SM, Di Nisio M, Kleinjan A, Beyer-Westendorf J, Camporese G, Kamphuisen PW, Büller HR, Bossuyt PM; ARMOUR study investigators.

Thromb Res. 2016 Dec;148:59-62. doi: 10.1016/j.thromres.2016.10.019. Epub 2016 Oct 24.

PMID:
27815967
43.

Improving the diagnostic management of upper extremity deep vein thrombosis.

van Es N, Bleker SM, Di Nisio M, Kleinjan A, Beyer-Westendorf J, Camporese G, Aggarwal A, Verhamme P, Righini M, Büller HR, Bossuyt PM.

J Thromb Haemost. 2017 Jan;15(1):66-73. doi: 10.1111/jth.13536. Epub 2016 Nov 28.

44.

Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots.

Bleker SM, Beenen LF, Di Nisio M, van Es N, Büller HR, Kraaijpoel N, Rutten A.

Thromb Res. 2016 Nov;147:46-51. doi: 10.1016/j.thromres.2016.09.015. Epub 2016 Sep 17.

PMID:
27669127
45.

Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trial.

Bleker SM, Cohen AT, Büller HR, Agnelli G, Gallus AS, Raskob GE, Weitz JI, Curto M, Sisson M, Middeldorp S.

Thromb Haemost. 2016 Nov 30;116(6):1159-1164. Epub 2016 Sep 1.

PMID:
27583312
46.

Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.

Brekelmans MP, Ageno W, Beenen LF, Brenner B, Buller HR, Chen CZ, Cohen AT, Grosso MA, Meyer G, Raskob G, Segers A, Vanassche T, Verhamme P, Wells PS, Zhang G, Weitz JI.

Lancet Haematol. 2016 Sep;3(9):e437-45. doi: 10.1016/S2352-3026(16)30080-1.

PMID:
27570090
47.

Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery.

Elbers LP, Boon HA, Moes MI, van Zaane B, Brandjes DP, Fliers E, Büller HR, Cannegieter S, Gerdes VE.

Eur Thyroid J. 2016 Jul;5(2):139-44. doi: 10.1159/000446431. Epub 2016 Jun 14.

48.

Managing reversal of direct oral anticoagulants in emergency situations. Anticoagulation Education Task Force White Paper.

Ageno W, Büller HR, Falanga A, Hacke W, Hendriks J, Lobban T, Merino J, Milojevic IS, Moya F, van der Worp HB, Randall G, Tsioufis K, Verhamme P, Camm AJ.

Thromb Haemost. 2016 Nov 30;116(6):1003-1010. Epub 2016 Aug 4.

PMID:
27488232
49.

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.

Raskob GE, van Es N, Segers A, Angchaisuksiri P, Oh D, Boda Z, Lyons RM, Meijer K, Gudz I, Weitz JI, Zhang G, Lanz H, Mercuri MF, Büller HR; Hokusai-VTE investigators.

Lancet Haematol. 2016 Aug;3(8):e379-87. doi: 10.1016/S2352-3026(16)30057-6. Epub 2016 Jul 1.

PMID:
27476789
50.

Deep vein thrombosis and pulmonary embolism.

Di Nisio M, van Es N, Büller HR.

Lancet. 2016 Dec 17;388(10063):3060-3073. doi: 10.1016/S0140-6736(16)30514-1. Epub 2016 Jun 30. Review.

PMID:
27375038

Supplemental Content

Loading ...
Support Center